Journey So Far
Journey So Far
1946
Contract manufacturing and distribution company for leading MNCs (SmithKline, Boots, Pfizer, Hoechst, Parke Davis, etc.)
1946
Entry into Indian Domestic Pharmaceutical Market from our Registered Office in Mumbai
1946
Introduced 1st Antitubercular Drugs in the Indian market in collaboration with Gruppo Lepetit and Bracco, Italy
Journey So Far
1989
Mr. Krishan Kumar Aurora took over Pharmed Limited in 1989, and since then, he led this company as the Chairman
1991
The Corporate Office was moved to the Bangalore City
1999
Introduced India's 1st Glucosamine brand, Cartigen®, in collaboration with Tishcon Corp., USA
2000
Introduced 1st Calcium Citrate brand (Supracal®, the best absorbed Calcium) in the Indian market in collaboration with Tishcon Corp., USA
Journey So Far
2008
Introduced the 1st comprehensive brand for Neurasthenia with bioenhancer Piperine advantage, Absolut® 3G in the Indian market
2010
Expanded our business with a new division, RIGEL
Journey So Far
2012
A major novel management to support tendon health, to prevent tendon degeneration was introduced; changed the tendon disease management
2012
Introduced 1st Pamabrom combination (PamaSpas®) for the management of PMS & dysmenorrhea, again a first of its kind
2013
We chose to mirror our success in Tendocare® to TendoFit®, a major novel management to support tendon health, to prevent tendon degeneration was introduced; changed the tendon disease management
2013
Introduced 1st L-Arginine with Glutathione, Rigin Plus®, changing the ways uteroplacental insufficiency and foetal growth restriction are managed
2013
Introduced 1st unique woman-specific multivitamin and mineral combination (Absolut® WOMAN) in the Indian market that changed the market scenario
2015
Introduced the unique combination of Magnesium for the 1st time in the Indian market
2015
Introduced the first teen-health specific formulation in the Indian market
2016
Introduced 1st time in India for supporting healing of advancing tendinopathies. Novel formulation with technologically advanced low-dose sustained-release L-Arginine with other unique low molecular weight ingredients
2016
Introduced the unique combination of Magnesium weekly dose kit for the treatment of subclinical magnesium deficiency & associated problems for the first time in the Indian market
2017
On January 1, 2017, under the new and reorganized management teams, the name of Rigel Division was changed to PHARMED ACE DIVISION
2017
Introduced India’s First Maternal Folate with IODINE advantage
2018
Introduced India's 1st alternative formulation to help management of synovial inflammation
2018
Novel once daily sachet formulation with Magnesium and other specific amino acids for better supportive management of osteoarthritis
2018
Introduced India's first Magnesium & L-Carnitine formulation to aid primary management of hypertension
2019
Introduced unique alcohol-based nanoformulation "Nanofast® 4x" for better penetration and better tissue concentration for faster pain relief
2020
On June 15, 2020, Pharmed Synergy was launched, dedicated to Orthopaedic and Gynecology therapy segment
Corporate Social Responsibility
CSR Policy
Our commitments towards Corporate Social Responsibility (CSR) includes promotion of healthcare and betterment of the society through respect for universal human rights
CSR Committee
To effectively implement the objectives of the Company with respect to CSR, the Committee is vested with functions and powers
CSR Projects
CSR has always been an integral part of Pharmed’s vision and is the cornerstone of our core value of Good Corporate Citizenship.
BMD Camps
Pharmed is thrilled to announce that we have impacted over 2 million lives across India through our social welfare initiatives for improving bone health